Floatz logo

HUMAN ANTIHEMOPHILIC FACTOR/VON WILLEBRAND FACTOR COMPLEX

Severe Hemophilia A

AryoGen Pharmed Co.protein_peptidePhase 4 / ApprovedActive
BBB
75/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
66/ 100
Competitive Position
89/ 100

Competitive context

9 Active assets in the Severe Hemophilia A cohort.

Asset / SponsorPhaseRating
Emicizumab
Chulalongkorn University
Phase 4BBB
Human-Cl Rhfviii
Octapharma
Phase 3BBB
Rfviiifc
Bioverativ Therapeutics Inc.
Phase 3BB
Alphanate Sd/Ht
Grifols Biologicals, LLC
Phase 4BB
Frsw117
Hangzhou Gensciences Biopharmaceutical Co., Ltd.
Phase 3BB

View all 21 →

Same molecule, other indications

HUMAN ANTIHEMOPHILIC FACTOR/VON WILLEBRAND FACTOR COMPLEX is also rated in:

inherited blood coagulation disorderDormant
BB
Indicative ·
69 / 100
View asset →
hemophilia BDormant
BB
Indicative ·
69 / 100
View asset →
hemophilia ADormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →